Rat neutralizing monoclonal antibody, nucleic acid encoding that antibody, pharmaceutical composition and use of the antibody or neutralizing fragment of said antibody in the manufacture of a medicament for the treatment of conditions involving IL-18
Chimeric, humanized and other IL-18 mAbs, derived from high affinity neutralizing mAbs, pharmaceutical compositions containing same, methods of treatment and diagnostics are provided.